This is suspended due to ongoing MHRA investigation into the device
Status | Discontinued |
Decision | Selected |
Process | MTG |
ID number | 169 |
Email enquiries
- If you have any queries please email Medtech@nice.org.uk
Stakeholders
External assessment group | Newcastle upon Tyne Hospitals |
Manufacturers | NuVasive, Inc. |
Professional groups | Association of British Healthcare Industries (ABHI) |
Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM) | |
Boston Scientific | |
Department of Health and Social Care | |
Devices for Dignity | |
Greater Manchester Health & Social Care Partnership | |
Healthcare Improvement Scotland | |
HealthTech Alliance | |
Johnson & Johnson Medical Ltd | |
Medical Technology Group | |
Medicines and Healthcare Products Regulatory Agency | |
NHS England | |
The British In Vitro Diagnostics Association (BIVDA) |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
22 December 2021 | Discontinued. This is suspended due to ongoing MHRA investigation into the device |
03 August 2020 | Resolution |
24 April 2020 | Committee meeting: 1 |
06 February 2020 | Scope published |
For further information on our processes and methods, please see our CHTE processes and methods manual